Bioxytran Competitors and Similar CompaniesClear all
Bioxytran's competitors and similar companies include Proteome Sciences, Versantis, Cellis and IMIDomics.
 Bioxytran Bioxytran (formerly known as U.S. Rare Earth Minerals) is a clinical stage pharmaceutical company developing platform technologies. |  Proteome Sciences Reaching New Heights in Biomarker Solutions-Protein and peptide biomarker solutions for pharmaceutical and diagnostics applications |  Versantis Versantis is a developer of liver disease therapeutics and diagnostics intended to provide the first drug capture platform for the treatment of life-threatening intoxications. |  Cellis Cellis is a company that develops therapeutic and diagnostic solutions with a focus on nanotechnology, oncology, and molecular biology. |  IMIDomics IMIDomics is a company that develops medicine diagnostics and therapeutics to optimize treatment of IMID (immune-mediated inflammatory diseases) patients. | |
Founding Date | Founding Date 2008 | Founding Date N/A | Founding Date 2015 | Founding Date 2015 | Founding Date 2015 |
Type | Type Public | Type Public | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Newton, US HQ Newton, US | Locations Addlestone, GB HQ Frankfurt Am Main, DE Cobham, GB | Locations Zürich, CH HQ | Locations Zürich, CH HQ Warsaw, PL | Locations HQ |
Employees | Employees 3 | Employees 363% increase | Employees 2 | Employees 23 | Employees 3 |
Valuation ($) | Valuation ($) 8.1 m | Valuation ($) 10.5 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Net income | Net income ($2.1m) (FY, 2025) | Net income (£3.1m) (FY, 2025) | Net income N/A | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 16.1m (over 6 years ago) | Latest funding round N/A | Latest funding round $ 16.5m (almost 5 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 20.7m | Total funding raised N/A | Total funding raised $ 16.5m |
For sources of this data, please see the company profile
View Company Profiles
Proteome Sciences
HQ
Addlestone, GB
Employees
36↑ 3% increase
Reaching New Heights in Biomarker Solutions-Protein and peptide biomarker solutions for pharmaceutical and diagnostics applications
View companyVersantis
HQ
Zürich, CH
Employees
2
Versantis is a developer of liver disease therapeutics and diagnostics intended to provide the first drug capture platform for the treatment of life-threatening intoxications.
View companyCellis
HQ
Zürich, CH
Employees
23
Cellis is a company that develops therapeutic and diagnostic solutions with a focus on nanotechnology, oncology, and molecular biology.
View companyIMIDomics
HQ
Employees
3
IMIDomics is a company that develops medicine diagnostics and therapeutics to optimize treatment of IMID (immune-mediated inflammatory diseases) patients.
View company